These figures come from public data and published research. Australian and global figures are never mixed in one chart. Methods, sources and caveats for every dataset are in research-data/SOURCES.md.
Chapter 1
Then
Global1977–1993
16 years
For 16 years, from 1977 to 1993, US rules kept women who could become pregnant out of early drug trials by default.
From 2026, Australia's main health research funders, the NHMRC and the Medical Research Future Fund, require the research they fund to consider sex and gender.
Women are 35% of heart disease trial participants but carry 39% of the burden.
Half of heart disease trials are less than 28.5% women.
Women's share of trial participants was below their share of the disease burden in 5 of 9 conditions. The biggest shortfall was in Alzheimer's and other dementias (58% of participants, 66% of the burden).Show the data
Women's share of trial participants and of the disease burden, by condition (sorted by the gap)
Condition
Trials
Women, all participants
Women, median trial
Women, share of burden
Alzheimer's and other dementias
862
58.4%
55.6%
65.6%
Low back pain
230
56.5%
55.4%
62.5%
Anxiety disorders
600
55.6%
63.0%
60.9%
Ischaemic heart disease
684
34.9%
28.5%
38.8%
Stroke
636
42.3%
40.0%
45.2%
Osteoarthritis
549
61.7%
60.1%
61.0%
Depressive disorders
1,277
63.2%
65.1%
60.4%
Rheumatoid arthritis
450
79.4%
80.1%
72.1%
Migraine
290
83.9%
83.9%
68.9%
Some trials are counted under more than one condition: 5,578 trial–condition entries, 5,198 distinct trials. Very large trials can skew the "all participants" share; the median trial is shown too.
Our analysis of 5,198 ClinicalTrials.gov trials (2010–2025) that reported participants by sex, compared with GBD 2023 burden (DALYs). Studies that compare with prevalence find similar patterns (Rivera et al., JAMA Netw Open 2025).
Low back pain gets 18.4 research papers per 100,000 years of healthy life lost. Heart disease gets 61.9.
Conditions people live with, rather than die from, tend to get less research.
Across 13 conditions, those whose burden comes mostly from living unwell tend to have fewer research papers per unit of burden (rank correlation -0.53). That is a pattern, not proof.Show the data
Research papers and type of burden, by condition
Condition
Papers per 100,000 DALYs
Burden from living unwell
Clearly hits women harder
Low back pain
18.4
100.0%
Yes
Migraine
27.5
100.0%
Yes
Anxiety disorders
50.9
100.0%
No
Ischemic heart disease
61.9
5.2%
No
Stroke
62.3
10.7%
No
Depressive disorders
72.7
100.0%
No
Osteoarthritis
166.8
100.0%
No
Cervical cancer
207.5
2.9%
No
Alzheimer's disease and other dementias
248.5
30.6%
No
Uterine cancer
401.7
9.0%
No
Ovarian cancer
498.5
2.7%
No
Breast cancer
550.0
6.5%
No
Rheumatoid arthritis
1,048.3
72.6%
Yes
PubMed papers 2015–2024 per 100,000 DALYs (GBD 2023). A rough measure of research attention across 13 conditions. Gynaecological conditions are left out because GBD's burden estimates for them are unreliable.
In Australia, women's rate of years lived with disability compared with men's: rheumatoid arthritis 2.7×, migraine 2.2×, low back pain 2.0×.Show the data
Years lived with disability per 100,000, age-standardised, Australia, 2023
60% of Australian women's burden of disease comes from living with illness, not from dying early.
Of all the healthy life Australian women lose to disease, 60% is lost to living with illness and 40% to dying early.Show the data
Share of the burden of disease, Australia (%)
Living with illness
Dying early
Women
60%
40%
Transcribed from AIHW, The health of women in Australia (2025), as cited on the home page. The source as cited gives women's figure only, so men aren't shown.
Burden of disease counts the years of healthy life lost, both to living with illness and to dying early.
Coronary heart disease killed 5,965 Australian women in 2025. Breast cancer killed 3,244.
About 16 women a day died from coronary heart disease, and about 9 a day from breast cancer. Each figure stands for 100 deaths, rounded to the nearest 100.Show the data
Australian women, deaths registered in 2025
Cause (ABS name)
Deaths
Deaths a day
Years of potential life lost
Ischaemic heart diseases (I20-I25)
5,965
16.3
13,959
Malignant neoplasm of breast (C50)
3,244
8.9
25,503
Deaths a day = deaths ÷ 365.
Breast cancer kills women younger, so it costs more years of life: 25,503 years of potential life lost, compared with 13,959 for coronary heart disease.
Heart disease death rates for Australian women fell by 80% between 1990 and 2023.
Fall in age-standardised death rates for Australian women, 1990 to 2023: heart disease 80%, stroke 71%, breast cancer 46%, ovarian cancer 36%, cervical cancer 47%.Show the data
Age-standardised death rates per 100,000, Australian women (GBD 2023)
Cause
1990
2010
2023
Fall, 1990–2023
Heart disease
132.2
47.9
26.1
80.3%
Stroke
61.3
29.4
17.8
70.9%
Breast cancer
26.5
18.4
14.4
45.8%
Ovarian cancer
7.3
5.8
4.6
36.4%
Cervical cancer
3.8
2.3
2.0
46.7%
Age-standardised rates; falls are similar for men. Investment in research, prevention and treatment works.
Cervical screening (ages 20–69), 2024: Australia 77.9%, median of 36 other countries 60.6%. Breast screening (ages 50–69), 2024: Australia 52.0%, median of 38 other countries 53.8%.Show the data
Women screened, programme data (%)
Screening
Year
Australia
Median, other countries
Countries reporting
Cervical screening (ages 20–69)
2024
77.9%
60.6%
36
Breast screening (ages 50–69)
2024
52.0%
53.8%
38
OECD status for Australia: cervical screening "Definition differs".
OECD measures breast screening at ages 50–69; BreastScreen Australia invites women aged 50–74. OECD flags Australia's cervical screening figure: "Definition differs".
People with endometriosis in Australia waited an average of eight years from their first symptoms to a diagnosis.
Average years from first seeing a doctor to an endometriosis diagnosis, by when people first saw a doctor: before 2005, 9.9 years; 2005–2012, 4.8 years; 2013 onwards, 1.5 years. Waits have got shorter, but the most recent group is cut short (see below).Show the data
Average years from first seeing a doctor to an endometriosis diagnosis (survey of 340 people, 2017)
First saw a doctor
Average years to diagnosis
before 2005
9.9
2005–2012
4.8
2013 onwards
1.5
The survey ran in 2017, so people first seen from 2013 who were still waiting weren't counted. A 2025 survey of 506 Australians found an average of 12.3 years from symptoms to diagnosis, and 4.7 years for people who first saw a GP from 2018. Both surveys recruited through endometriosis groups, so they aren't representative.